Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy.
暂无分享,去创建一个
M. Roncarolo | R. Bacchetta | A. Cepika | Ece Canan Sayitoğlu | B. Cieniewicz | Ping‐le Chen | J. Liu | M. Uyeda | Benjamin Craig Thomas | Yohei Sato | E. C. Sayitoğlu